Sri Agasthya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 1.00 M
as on 21-12-2024
- Company Age 1 Year 10 Months
- Last Filing with ROC 31 Mar 2023
About Sri Agasthya Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Srilatha Reddy, Suchi Indumouli, and Charan Vadavala serve as directors at the Company.
- CIN/LLPIN
U20297TS2023PTC171154
- Company No.
171154
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2023
- Date of AGM
15 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Agasthya Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srilatha Reddy  | Director | 16-Mar-2023 | Current |
| Suchi Indumouli | Director | 11-Sep-2023 | Current |
| Charan Vadavala | Director | 06-Aug-2024 | Current |
Financial Performance of Sri Agasthya Life Sciences.
Sri Agasthya Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sri Agasthya Life Sciences?
Unlock access to Sri Agasthya Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Agasthya Sustainable Polymers Private LimitedActive 1 year 5 months
Suchi Indumouli and Charan Vadavala are mutual person
- Agasthya Global Brands Private LimitedActive 1 year 8 months
Suchi Indumouli and Charan Vadavala are mutual person
- Agastya Research Farms Private LimitedActive 5 years 1 month
Suchi Indumouli and Charan Vadavala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Agasthya Life Sciences?
Unlock and access historical data on people associated with Sri Agasthya Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Agasthya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Agasthya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
